N-ALKYL SULFONYL HYDRAZONES
3355
pressure, and the residue was separated by silica-gel (Merck 230–240 mesh) column
chromatography using hexane–ethyl acetate mixture as eluent.
N’1-[(4-Chlorophenyl)methylene]-N1,4-dimethyl-1-
benzenesulfonohydrazide (3a)
White powder, mp: 152 ꢁC, yield: 0.27 g (85%). IR (KBr): 2932, 1559, 1468,
1353, 1161, 1093, 929, 819, 676, 547. 1H NMR (400.1 MHz, CDCl3): dH ¼ 2.41
(3H, s, Me), 3.24 (3H, s, NMe), 7.30 (2H, d, J ¼ 8.8 Hz, 2CH), 7.36 (2H, d,
J ¼ 6.8 Hz, 2CH), 7.52 (1H, s, CH), 7.59 (2H, d, J ¼ 6.8 Hz, 2CH), 7.79 (2H, d,
J ¼ 8.8 Hz, 2CH). 13C NMR (100.6 MHz, CDCl3): dC ¼ 21.5 (Me), 33.2 (NMe),
128.1 (2CH), 128.3 (2CH), 128.9 (2CH), 129.5 (2CH), 132.7 (C), 133.4 (C), 135.7
(C), 141.8 (CH), 144.2 (C). EI-MS: 322 (Mþ, 5), 277 (20), 167 (100), 152 (25), 132
(30), 111 (25), 84 (85), 65 (32). Anal. calc. for C15H15ClN2O2S (322.80): C, 55.81;
H, 4.68; N, 8.68. Found: C, 55.81; H, 4.50; N, 8.31.
Supplementary Material
1
Full experimental details and H and 13C NMR spectra can be found via the
Supplementary Content section of this article’s Web page.
REFERENCES
1. Sakya, S. M.; Hou, X. J.; Minich, M. L.; Rast, B.; Shavnya, A.; DeMello, K. M. L.;
Cheng, H.; Li, J.; Jaynes, B. H.; Mann, D. W.; Petras, C. F.; Seibel, S. B.; Haven, M.
L. 5-Heteroatom-substituted pyrazoles as canine COX-2 inhibitors, part 3: Molecular
modeling studies on binding contribution of 1-(5-methylsulfonyl)pyrid-2-yl and 4-nitrile.
Bioorg. Med. Chem. Lett. 2007, 17, 1067–1072.
2. Sasikumar, T. K.; Qiang, L.; Burnett, D. A.; Cole, D.; Xu, R.; Li, H. M.; Greenlee, W. J.;
Clader, J.; Zhang, L.; Hyde, L. Tricyclic sulfones as orally active v-secretase inhibitors:
Synthesis and structure–activity relationship studies. Bioorg. Med. Chem. Lett. 2010, 20,
3632–3635.
3. Di Santo, R.; Costi, R.; Artico, N.; Rango, R.; Lavecchia, A.; Novellino, E.; Gavuzzo, E.;
La Torre, F.; Cirilli, R.; Cancio, R.; Maga, G. Design synthesis, biological evaluation, and
molecular modeling studies of TIBO-like cyclic sulfones as non-nucleoside HIV-1 reverse
transcriptase inhibitors. Chem. Med. Chem. 2006, 16, 82–95.
4. Cheung, W. H.; Zheng, S. L.; Yu, W. Y.; Zhou, G. C.; Che, C. M. Ruthenium porphyrin–
catalyzed intramolecular carbenoid C-H insertion: Stereoselective synthesis of cis-disubsti-
tuted oxygen and nitrogen heterocycles. Org. Lett. 2003, 5, 2535–2538.
5. Fulton, J. R.; Aggarwal, V. K.; de Vicente, J. The use of tosylhydrazone salts as a safe
alternation for handling diazo compounds and their applications in organic synthsis.
Eur. J. Org. Chem. 2005, 1479–1492.
6. Aggarwal, V. K.; de Vicente, J.; Bonnert, R. V. Catalytic cyclopropanation of alkenes
using diazo compounds generated in situ: A novel to 2-arylcyclopropylamines. Org. Lett.
2001, 3, 2785–2788.
7. Aggarwal, V. K.; Bae, I.; Lee, H. Y.; Richardson, J.; Williams, D. T. Sulfur-ylide-
mediated synthesis of functionalized and trisubstituted epoxides with high enantioselec-
tivy: Application to the synthesis of CDP-840. Angew. Chem. Int. Ed. 2003, 42, 3274–3278.